Changes in haemostatic parameters during the menstrual cycle and drospirenone-containing oral contraceptive use

被引：0
|
作者：
Tchaikovski, S. N. [1 ]
Thomassen, C. L. G. D. [2 ]
Costa, S. D. [1 ]
Bremme, K. [3 ]
Jan, R. [2 ]
机构：
[1] Otto Von Guericke Univ, Magdeburg, Germany
[2] Cardiovasc Reasearch Inst Maastricht, Maastricht, Netherlands
[3] Karolinska Inst, Stockholm, Sweden
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：739 / 739
页数：1
相关论文
共 50 条
  • [31] Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: An Assessment of Risk in First-Time Users and Restarters
    Natasha Larivée
    Samy Suissa
    Janie Coulombe
    Vicky Tagalakis
    Kristian B. Filion
    [J]. Drug Safety, 2017, 40 : 583 - 596
  • [32] Weight change with oral contraceptive use and during the menstrual cycle -: Results of daily measurements
    Rosenberg, M
    [J]. CONTRACEPTION, 1998, 58 (06) : 345 - 349
  • [33] SERUM LEVELS OF RELAXIN DURING THE MENSTRUAL-CYCLE AND ORAL-CONTRACEPTIVE USE
    WREJE, U
    KRISTIANSSON, P
    ABERG, H
    BYSTROM, B
    VONSCHOULTZ, B
    [J]. GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1995, 39 (03) : 197 - 200
  • [34] Drospirenone-Containing Oral Contraceptives and Risk of Adverse Outcomes After Myocardial Infarction
    Karabay, Can Yucel
    Kocabay, Gonenc
    Oduncu, Vecih
    Kalayci, Arzu
    Guler, Ahmet
    Karagoz, Ali
    Candan, Ozkan
    Basaran, Ozcan
    Zehir, Regayip
    Izgi, Akin
    Esen, Ali Metin
    Kirma, Cevat
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2013, 82 (03) : 387 - 393
  • [35] ADMA concentration changes across the menstrual cycle and during oral contraceptive use: the Cardiovascular Risk in Young Finns Study
    Valtonen, Pirjo
    Punnonen, Kari
    Saarelainen, Heli
    Heiskanen, Nonna
    Raitakari, Olli T.
    Juonala, Markus
    Viikari, Jorma S. A.
    Alfthan, Georg
    Kahonen, Mika
    Laaksonen, Reijo
    Lyyra-Laitinen, Tiina
    Laitinen, Tomi
    Heinonen, Seppo
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2010, 162 (02) : 259 - 265
  • [36] Clotting factor changes during the first cycle of oral contraceptive use
    Westhoff, Carolyn L.
    Eisenberger, Andrew
    Tang, Rosalind
    Cremers, Serge
    Grossman, Lisa V.
    Pike, Malcolm C.
    [J]. CONTRACEPTION, 2016, 93 (01) : 70 - 76
  • [37] Bleeding pattern, tolerance and patient satisfaction with a drospirenone-containing oral contraceptive evaluated in 3488 women in Europe, the Middle East and Canada
    Endrikat, Jan S.
    Milchev, Nikola P.
    Kapamadzija, Aleksandra
    Georgievska, Jadranka
    Gerlinger, Christoph
    Schmidt, Werner
    Feroze, Sleem
    [J]. CONTRACEPTION, 2009, 79 (06) : 428 - 432
  • [38] Safety and efficacy of a new oral contraceptive containing drospirenone
    Shulman, LP
    [J]. JOURNAL OF REPRODUCTIVE MEDICINE, 2002, 47 (11) : 981 - 984
  • [39] Changes Of Coagulation Parameters During The Menstrual Cycle
    Halimeh, Susan
    Rott, Hannelore
    Kappert, Guenther
    Siebert, Manuela
    [J]. BLOOD, 2013, 122 (21)
  • [40] Evaluation of platelets count and activation during menstrual cycle in young women in oral contraceptive use
    Dusse, L. M. S.
    Freitas, L. G.
    Loures, C. G.
    Silva, M., V
    Nunes, F. F.
    Carvalho, M. G.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 925 - 925
12345